UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000039301 |
|---|---|
| Receipt number | R000044825 |
| Scientific Title | Study of changes in blood amino acid concentration by ingestion of test food |
| Date of disclosure of the study information | 2020/02/26 |
| Last modified on | 2024/08/16 17:54:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study of changes in blood amino acid concentration by ingestion of test food
Acronym
Study of changes in blood amino acid concentration by ingestion of test food
Scientific Title
Study of changes in blood amino acid concentration by ingestion of test food
Scientific Title:Acronym
Study of changes in blood amino acid concentration by ingestion of test food
Region
| Japan |
Condition
Condition
None
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Study of changes in blood amino acid concentration over time by ingestion of test food
Basic objectives2
Others
Basic objectives -Others
Absorption kinetics after food ingestion
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Plasma amino acids concentration
Key secondary outcomes
plasma glucose and insulin concentration
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
5
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Ingestion of study foodA substance (Once).
Interventions/Control_2
Ingestion of study foodB substance (Once).
Interventions/Control_3
Ingestion of study foodC substance (Once).
Interventions/Control_4
Ingestion of study foodD substance (Once).
Interventions/Control_5
Ingestion of study foodE substance (Once).
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 60 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1) Japanese individuals aged 20-60 years.
2) Individuals who are healthy and are not suffered from a chronic malady.
3) Individuals whose written informed consent has been obtained.
4) Individuals who can visit an inspection facility and be inspected in designated days.
5) Individuals judged appropriate for the study by the principal.
6) Individuals who are not resistant to blood sampling.
Key exclusion criteria
1)Individuals using medical products.
2)Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung and blood disease.
3)Individuals who contract or have a history of serious gastrointestinal disease.
4)Individuals who have an addiction to alcohol or a mental illness.
5)Individuals who used or applied a drug for treatment of disease in the past 1 month.
6)Individuals with probable seasonal allergy, such as pollinosis, during the test period.(In particular, Betulaceae: alder, oba alnus firma, shirakaba, Taxodiaceae: cryptomeria, hinoki cypress, Asteraceae: ragweed, Artemisia vulgaris indica, Gramineae:Dactylis glomerata, Phleum pratense)
7)Individuals who have possibility of allergy symptoms onset by the test food and who cause severe allergic symptoms in foods and medicines.
8)Individuals cannnot drink milk or dairy products.
9)Individuals with serious anemia.
10)Individuals with high blood glucose(fasting blood glucose over 126mg/dL).
11)Individuals who are a smoker.
12)Females who are or are possibly pregnant, or are lactating.
13)Individuals whose life style will change during the test period.
14)Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period.
15)Individuals who were hospitalized and received treatment in the past 6 months.
16)Individuals who participated in other clinical studies in the past 1 months or will participate in other clinical studies during the test period.
17)Individuals judged inappropriate for the study by the principal.
Target sample size
12
Research contact person
Name of lead principal investigator
| 1st name | Hiroko |
| Middle name | |
| Last name | Uchida |
Organization
MORINAGA & CO., LTD.
Division name
Health Science and Research Center, R&D institute
Zip code
230-8504
Address
2-1-1, Shimodueyoshi, Tsurumi-ku, Yokohama
TEL
045-571-6140
h-uchida-ji@morinaga.co.jp
Public contact
Name of contact person
| 1st name | Takayuki |
| Middle name | |
| Last name | Yamamoto |
Organization
MORINAGA & CO., LTD.
Division name
Health Science and Research Center, R&D institute
Zip code
230-8504
Address
2-1-1, Shimodueyoshi, Tsurumi-ku, Yokohama
TEL
045-571-6140
Homepage URL
t-yamamoto-jc@morinaga.co.jp
Sponsor or person
Institute
MORINAGA & CO., LTD.
Institute
Department
Personal name
Funding Source
Organization
MORINAGA & CO., LTD.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Japan Conference of Clinical Research
Address
1-13-23 Minamiikebukuro, Toshima-ku, Tokyo
Tel
03-6868-7022
None
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 02 | Month | 26 | Day |
Related information
URL releasing protocol
https://www.mdpi.com/2218-1989/12/4/282
Publication of results
Published
Result
URL related to results and publications
https://www.mdpi.com/2218-1989/12/4/282
Number of participants that the trial has enrolled
11
Results
https://www.mdpi.com/2218-1989/12/4/282
Results date posted
| 2024 | Year | 08 | Month | 16 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
https://www.mdpi.com/2218-1989/12/4/282
Participant flow
https://www.mdpi.com/2218-1989/12/4/282
Adverse events
https://www.mdpi.com/2218-1989/12/4/282
Outcome measures
https://www.mdpi.com/2218-1989/12/4/282
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2020 | Year | 01 | Month | 07 | Day |
Date of IRB
| 2020 | Year | 01 | Month | 16 | Day |
Anticipated trial start date
| 2020 | Year | 01 | Month | 17 | Day |
Last follow-up date
| 2020 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2020 | Year | 01 | Month | 29 | Day |
Last modified on
| 2024 | Year | 08 | Month | 16 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044825
